Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small cell lung cancer with a PD-L1 expression level of >/= 1% by the U.S. Food and Drug Administration
Mountzios, G Remon, J Novello, S Blais, N Califano, Raffaele Cufer, T Dingemans, A Liu, SV Peled, N Pennell, NA
Mountzios, G
Remon, J
Novello, S
Blais, N
Califano, Raffaele
Cufer, T
Dingemans, A
Liu, SV
Peled, N
Pennell, NA
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Article
Citation
Mountzios G, Remon J, Novello S, Blais N, Califano R, Cufer T, et al. Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small cell lung cancer with a PD-L1 expression level of >/= 1% by the U.S. Food and Drug Administration. Ann Oncol. 2019 Sep 3.